Gyre Therapeutics (GYRE) Notes Payables (2015 - 2017)

Gyre Therapeutics (GYRE) posted quarterly Notes Payables of $5.1 million for Q4 2017, down 73.79% year-over-year from $19.4 million in Q4 2016, and down 7.34% quarter-over-quarter from $5.5 million in Q3 2017.

Gyre Therapeutics (GYRE) Notes Payables (2015 - 2017) Analysis & Trends

Gyre Therapeutics (GYRE) has reported Notes Payables for 3 consecutive years, with $5.1 million the latest figure, recorded in Q4 2017.

  • In Q4 2017, Notes Payables fell 73.79% year-over-year to $5.1 million; the TTM figure through Dec 2017 stood at $5.1 million (down 73.79% YoY), while the FY2017 annual figure was $5.1 million, down 73.79% from the prior year.
  • Notes Payables eased to $5.1 million in Q4 2017 per GYRE's latest filing, from $5.5 million in the prior quarter.
  • Across five years, Notes Payables topped out at $34.8 million in Q3 2015 and bottomed at $130000.0 in Q2 2016.
  • Historically, Notes Payables has averaged $14.7 million across 3 years, with a median of $9.2 million in 2017.
  • On a YoY basis, Notes Payables climbed as much as 6354.59% in 2017 and fell as far as 81.5% in 2017.
  • Gyre Therapeutics' Notes Payables stood at $33.7 million in 2015, then slumped by 42.5% to $19.4 million in 2016, then sank by 73.79% to $5.1 million in 2017.
  • Business Quant data shows GYRE's Notes Payables at $5.1 million in Q4 2017, $5.5 million in Q3 2017, and $5.8 million in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Gyre Therapeutics 708.31 Mn 685.47 Mn 26.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2017 5.09 Mn
Sep 30, 2017 5.49 Mn
Jun 30, 2017 5.77 Mn
Mar 31, 2017 12.65 Mn
Dec 31, 2016 19.40 Mn
Sep 30, 2016 29.67 Mn
Jun 30, 2016 130,000.00
Mar 31, 2016 196,000.00
Dec 31, 2015 33.74 Mn
Sep 30, 2015 34.78 Mn